Merck KGaA - Insider Trading & Ownership

Entity
Company
Location
Frankfurter Str. 250, Darmstadt, Germany
Summary
The estimated value of insider holdings of Merck KGaA is at least $565K dollars as of October 26, 2021. Merck KGaA is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $565K.
All Insider Reports
All Insider Reports

Ownership of Merck KGaA

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XLO Xilio Therapeutics, Inc. 10%+ Owner $565K Oct 26, 2021

Insider Transactions Reported by Merck KGaA:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.